Pluvicto Archives -

Novartis has shut down production of its radioligand therapies – one of its key growth areas – at

Manufacturing foul-up hits Novartis’ radioligand business

https://pharmaphorum.com/news/manufacturing-foul-up-hits-novartis-radioligand-business/

The UK regulator has said eligible patients with prostate cancer will get early access to a radioligand therapy

UK grants early access to Novartis’ prostate cancer radioligand

https://pharmaphorum.com/news/uk-grants-early-access-to-novartis-prostate-cancer-radioligand/

Novartis has been steadily investing in radiopharmaceuticals over the last few years, and one of those deals has

Novartis gets first OK for radioligand Pluvicto in prostate cancer

https://pharmaphorum.com/news/novartis-gets-first-ok-for-radioligand-pluvicto-in-prostate-cancer/

Pluvicto